Literature DB >> 26714725

Evaluating the Role of Viral Proteins in HIV-Mediated Neurotoxicity Using Primary Human Neuronal Cultures.

Vasudev R Rao1, Eliseo A Eugenin2,3, Vinayaka R Prasad4.   

Abstract

Despite the inability of HIV-1 to infect neurons, over half of the HIV-1-infected population in the USA suffers from neurocognitive dysfunction. HIV-infected immune cells in the periphery enter the central nervous system by causing a breach in the blood-brain barrier. The damage to the neurons is mediated by viral and host toxic products released by activated and infected immune and glial cells. To evaluate the toxicity of any viral isolate, viral protein, or host inflammatory protein, we describe a protocol to assess the neuronal apoptosis and synaptic compromise in primary cultures of human neurons and astrocytes.

Entities:  

Keywords:  Chemokines; Cytokines; HAD; HAND; HIV-1; HIV-associated dementia; HIV-associated neurocognitive dysfunction; Neuro-inflammation; Neuronal apoptosis; Neuronal damage; Tat; gp120

Mesh:

Substances:

Year:  2016        PMID: 26714725      PMCID: PMC5050920          DOI: 10.1007/978-1-4939-3046-3_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

1.  Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals.

Authors:  S F An; M Groves; F Gray; F Scaravilli
Journal:  J Neuropathol Exp Neurol       Date:  1999-11       Impact factor: 3.685

Review 2.  Mechanisms of the blood-brain barrier disruption in HIV-1 infection.

Authors:  Michal Toborek; Yong Woo Lee; Govinder Flora; Hong Pu; Ibolya E András; Edward Wylegala; Bernhard Hennig; Avindra Nath
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 3.  Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection.

Authors:  M S Meltzer; D R Skillman; P J Gomatos; D C Kalter; H E Gendelman
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

4.  Early penetration of the blood-brain-barrier by HIV.

Authors:  L Resnick; J R Berger; P Shapshak; W W Tourtellotte
Journal:  Neurology       Date:  1988-01       Impact factor: 9.910

5.  HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.

Authors:  Robert K Heaton; Donald R Franklin; Ronald J Ellis; J Allen McCutchan; Scott L Letendre; Shannon Leblanc; Stephanie H Corkran; Nichole A Duarte; David B Clifford; Steven P Woods; Ann C Collier; Christina M Marra; Susan Morgello; Monica Rivera Mindt; Michael J Taylor; Thomas D Marcotte; J Hampton Atkinson; Tanya Wolfson; Benjamin B Gelman; Justin C McArthur; David M Simpson; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Terry L Jernigan; Joseph Wong; Igor Grant
Journal:  J Neurovirol       Date:  2010-12-21       Impact factor: 2.643

6.  Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activation.

Authors:  Monica Airoldi; Alessandra Bandera; Daria Trabattoni; Benedetta Tagliabue; Beatrice Arosio; Alessandro Soria; Veronica Rainone; Giuseppe Lapadula; Giorgio Annoni; Mario Clerici; Andrea Gori
Journal:  Clin Dev Immunol       Date:  2012-03-27

7.  The gp120 protein is a second determinant of decreased neurovirulence of Indian HIV-1C isolates compared to southern African HIV-1C isolates.

Authors:  Vasudev R Rao; Ujjwal Neogi; Eliseo Eugenin; Vinayaka R Prasad
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

8.  Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.

Authors:  Vasudev R Rao; Ujjwal Neogi; Joshua S Talboom; Ligia Padilla; Mustafizur Rahman; Cari Fritz-French; Sandra Gonzalez-Ramirez; Anjali Verma; Charles Wood; Ruth M Ruprecht; Udaykumar Ranga; Tasnim Azim; John Joska; Eliseo Eugenin; Anita Shet; Heather Bimonte-Nelson; William R Tyor; Vinayaka R Prasad
Journal:  Retrovirology       Date:  2013-06-08       Impact factor: 4.602

Review 9.  Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND).

Authors:  Vasudev R Rao; Arthur P Ruiz; Vinayaka R Prasad
Journal:  AIDS Res Ther       Date:  2014-05-19       Impact factor: 2.250

  9 in total
  3 in total

1.  Identification, Localization, and Quantification of HIV Reservoirs Using Microscopy.

Authors:  Lisa Prevedel; Nancy Ruel; Paul Castellano; Carla Smith; Shaily Malik; Courtney Villeux; Morgane Bomsel; Susan Morgello; Eliseo A Eugenin
Journal:  Curr Protoc Cell Biol       Date:  2018-09-28

2.  4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol} (TIMBD) suppresses HIV1-gp120 mediated production of IL6 and IL8 but not CCL5.

Authors:  Fatma Abdalla; Anantha Nookala; Subhash B Padhye; Anil Kumar; Hari K Bhat
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

3.  Infusion of HIV-1 Nef-expressing astrocytes into the rat hippocampus induces enteropathy and interstitial pneumonitis and increases blood-brain-barrier permeability.

Authors:  Jocelyn Rivera; Raymond A Isidro; Raisa Y Loucil-Alicea; Myrella L Cruz; Caroline B Appleyard; Angel A Isidro; Gladys Chompre; Krystal Colon-Rivera; Richard J Noel
Journal:  PLoS One       Date:  2019-11-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.